SQSTM1 and Alzheimer disease: By performing WB analyses on postmortem human samples (Fig. 9a), we observed that LC3-II levels, the ratio of LC3-II to LC3-I, and p62 levels were significantly increased in AD brain samples when compared to non-AD controls.